View More Recent Stories

May 23, 2017 03:00PM Veracyte Announces Clinical Validation Data Demonstrating Envisia™ Genomic Classifier's Performance in Improving Idiopathic Pulmonary Fibrosis Diagnosis Presented at ATS 2017
May 18, 2017 12:20PM Veracyte (VCYT) Reports Anthem Coverage for Afirma GEC for Use in Thyroid Cancer Diagnosis
May 18, 2017 12:18PM Veracyte Announces Anthem Coverage for the Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis
May 11, 2017 08:30AM Data Demonstrating Cost-Effectiveness of Veracyte's Percepta® Bronchial Genomic Classifier Published in "Journal of Thoracic Oncology"
May 10, 2017 08:00AM Veracyte Announces Six Studies Highlighting Value of Company's Genomic Classifiers in Lung Cancer and Idiopathic Pulmonary Fibrosis To Be Presented at ATS 2017
May 8, 2017 08:00AM Data Presented at AACE 2017 Annual Meeting Demonstrate Long-Term Clinical Utility Of Veracyte's Afirma® Gene Expression Classifier in Thyroid Cancer Diagnosis
May 4, 2017 04:05PM Veracyte Announces Pivotal Clinical Validation Data for Next-Generation Afirma® Test To Help More Patients Avoid Unnecessary Surgery in Thyroid Cancer Diagnosis
May 3, 2017 04:05PM Veracyte Announces First Quarter 2017 Financial Results
Apr 26, 2017 08:00AM Veracyte Announces Multiple Studies Demonstrating Powerful Results from Afirma® Classifiers To Be Presented at the AACE 2017 Annual Meeting
Apr 19, 2017 04:30PM Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results on Wednesday, May 3, 2017
Apr 3, 2017 12:03PM Veracyte (VCYT) Presents Positive Data at ENDO 2017 Supporting Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis
Apr 3, 2017 12:00PM Multiple Studies Presented at ENDO 2017 Support Use of Veracyte's Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis
Mar 23, 2017 08:03AM Veracyte (VCYT) Says Multiple Studies Supporting Clinical Utility of Afirma Gene Expression Classifier to Be Presented at ENDO
Mar 23, 2017 08:00AM Veracyte Announces that Multiple Studies Supporting Clinical Utility of Its Afirma® Gene Expression Classifier To Be Presented at ENDO 2017
Mar 1, 2017 04:05PM Veracyte Announces Fourth Quarter and Full-Year 2016 Financial Results, Provides 2017 Financial Outlook
Feb 28, 2017 04:05PM Veracyte Announces Executive Promotions
Feb 27, 2017 10:22AM Veracyte (VCYT) Announces Publication of Data Showing Potential for Non-Invasive Nasal Test to Improve Lung Cancer Diagnosis
Feb 27, 2017 10:20AM Veracyte Announces Publication of Data Demonstrating Potential for Non-Invasive Nasal Test to Improve Lung Cancer Diagnosis
Feb 21, 2017 08:00AM Veracyte Announces Ten New Blues Plan Coverage Policies for Its Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis
Feb 15, 2017 08:00AM Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2016 Financial Results on Wednesday, March 1, 2017
Feb 8, 2017 08:05AM Veracyte (VCYT) Enters Agreement with Quest Diagnostics (DGX) to Expand Patient Access to GEC
Feb 8, 2017 08:00AM Veracyte to Expand Patient Access to the Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement with Quest Diagnostics
Feb 6, 2017 08:08AM Veracyte (VCYT) Announces Final Medicare Coverage Policies for Percepta
Feb 6, 2017 08:00AM Veracyte Announces Final Medicare Coverage Policies for Percepta® Bronchial Genomic Classifier
Feb 2, 2017 08:00AM Veracyte to Present at LEERINK Partners 6th Annual Global Healthcare Conference
View More Recent Stories